Literature DB >> 17299734

The association of the HOPA(12bp) polymorphism with schizophrenia in the NIMH Genetics Initiative for Schizophrenia sample.

Robert A Philibert1, Phil Bohle, Dianna Secrest, Jessica Deaderick, Harinder Sandhu, Raymond Crowe, Donald W Black.   

Abstract

HOPA (MED12) is an X-chromosome gene that codes for a critical member of the Mediator Complex, a group of proteins that regulates transcription via the nuclear receptor, Wnt and Receptor Tyrosine Kinase pathways. In prior association and meta-analyses, we have shown that the presence of an evolutionarily conserved, 12 bp (4 amino acid) insertional polymorphism in exon 43 of this gene is associated with increased risk for an endophenotype of schizophrenia. In this communication, we describe the results of our work with subjects and data from the National Institutes of Mental Health (NIMH) Genetics Initiative for Schizophrenia. We report that the presence of the HOPA(12bp) polymorphism is associated with increased risk for schizophrenia in subjects of European ancestry. In the light of this new study and the prior wealth of clinical and basic science data, we conclude that the HOPA(12bp) allele is a risk factor for schizophrenia in subjects of European ancestry and suggest that further studies to define the endophenotype and mechanisms of illness associated with this polymorphism are indicated. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299734     DOI: 10.1002/ajmg.b.30489

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Sex-specific rates of transmission of psychosis in the New England high-risk family study.

Authors:  Jill M Goldstein; Sara Cherkerzian; Larry J Seidman; Tracey L Petryshen; Garrett Fitzmaurice; Ming T Tsuang; Stephen L Buka
Journal:  Schizophr Res       Date:  2011-02-18       Impact factor: 4.939

Review 2.  Mediator and human disease.

Authors:  Jason M Spaeth; Nam Hee Kim; Thomas G Boyer
Journal:  Semin Cell Dev Biol       Date:  2011-08-04       Impact factor: 7.727

Review 3.  Transcriptional regulation and its misregulation in disease.

Authors:  Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

4.  Characterization and classification of zebrafish brain morphology mutants.

Authors:  Laura Anne Lowery; Gianluca De Rienzo; Jennifer H Gutzman; Hazel Sive
Journal:  Anat Rec (Hoboken)       Date:  2009-01       Impact factor: 2.064

Review 5.  Totally tubular: the mystery behind function and origin of the brain ventricular system.

Authors:  Laura Anne Lowery; Hazel Sive
Journal:  Bioessays       Date:  2009-04       Impact factor: 4.345

6.  Adaptive evolution of genes underlying schizophrenia.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Proc Biol Sci       Date:  2007-11-22       Impact factor: 5.349

7.  d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.

Authors:  Kirsten C Svane; Ericka-Kate Asis; Anton Omelchenko; Ansley J Kunnath; Linda M Brzustowicz; Steven M Silverstein; Bonnie L Firestein
Journal:  Mol Cell Neurosci       Date:  2018-03-27       Impact factor: 4.314

8.  Mediator subunit Med12 contributes to the maintenance of neural stem cell identity.

Authors:  Nam Hee Kim; Carolina B Livi; P Renee Yew; Thomas G Boyer
Journal:  BMC Dev Biol       Date:  2016-05-17       Impact factor: 1.978

9.  Methylation of the MAOA promoter is associated with schizophrenia.

Authors:  Hao Yang; Jiajue Li; Aicen Ji; Liping Hu; Xiufeng Zhang; Linlin Liu; Lili Qing; Ming Yan; Shengjie Nie
Journal:  Ann Transl Med       Date:  2020-07

10.  Novel oxytocin gene expression in the hindbrain is induced by alcohol exposure: transgenic zebrafish enable visualization of sensitive neurons.

Authors:  Caitrín M Coffey; Patricia A Solleveld; Joyce Fang; Antonia K Roberts; Sung-Kook Hong; Igor B Dawid; Caroline E Laverriere; Eric Glasgow
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.